Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. Gnant M, Fitzal F, Rinnerthaler G, Steger GG, et al. N Engl J Med 2021;385:395-405.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gnant M, Fitzal F, Rinnerthaler G, Steger GG, et al. Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. N Engl J Med 2021;385:395-405.
PMID: 34320285